Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemente García-Rizo

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Data in Brief|July 10, 2020
Data of a meta-analysis on pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemiaJavier Labad, Itziar Montalvo, Alexandre González-Rodríguez, et al.
Pharmacopsychiatry|April 15, 2024
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum DisorderVicent Llorca-Bofí, Miquel Bioque, Santiago Madero, et al.
Schizophrenia Research|June 9, 2020
Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysisJavier Labad, Itziar Montalvo, Alexandre González-Rodríguez, et al.
Schizophrenia Research|April 17, 2026
Perinatal stress as a moderator of the effects of hormonal dysregulation on cognition and symptoms in early psychosisEstefania Gago, Itziar Montalvo, Ángel Cabezas, et al.
Journal of Psychiatric Research|March 27, 2024
Changes in BDNF methylation patterns after cognitive remediation therapy in schizophrenia: A randomized and controlled trialRafael Penadés, Carmen Almodóvar-Payá, Clemente García-Rizo, et al.
Biological Psychiatry|March 5, 2013
Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging studyRafael Penadés, Nuria Pujol, Rosa Catalán, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 17, 2020
Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image studyMiquel Bioque, Eduard Parellada, Clemente García-Rizo, et al.
Schizophrenia Research|January 19, 2016
Cortical thickness in regions of frontal and temporal lobes is associated with responsiveness to cognitive remediation therapy in schizophreniaRafael Penadés, Nuria Pujol, Rosa Catalán, et al.
Schizophrenia Research|December 25, 2017
BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trialRafael Penadés, Irene López-Vílchez, Rosa Catalán, et al.
Revista De Psiquiatria Y Salud Mental|April 13, 2016
Validation of the Spanish version of the McLean Screening Instrument for Borderline Personality DisorderJoaquim Soler, Elisabet Domínguez-Clavé, Clemente García-Rizo, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Data in Brief|July 10, 2020
Data of a meta-analysis on pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemiaJavier Labad, Itziar Montalvo, Alexandre González-Rodríguez, et al.
Pharmacopsychiatry|April 15, 2024
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum DisorderVicent Llorca-Bofí, Miquel Bioque, Santiago Madero, et al.
Schizophrenia Research|June 9, 2020
Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysisJavier Labad, Itziar Montalvo, Alexandre González-Rodríguez, et al.
Schizophrenia Research|April 17, 2026
Perinatal stress as a moderator of the effects of hormonal dysregulation on cognition and symptoms in early psychosisEstefania Gago, Itziar Montalvo, Ángel Cabezas, et al.
Journal of Psychiatric Research|March 27, 2024
Changes in BDNF methylation patterns after cognitive remediation therapy in schizophrenia: A randomized and controlled trialRafael Penadés, Carmen Almodóvar-Payá, Clemente García-Rizo, et al.
Biological Psychiatry|March 5, 2013
Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging studyRafael Penadés, Nuria Pujol, Rosa Catalán, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 17, 2020
Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image studyMiquel Bioque, Eduard Parellada, Clemente García-Rizo, et al.
Schizophrenia Research|January 19, 2016
Cortical thickness in regions of frontal and temporal lobes is associated with responsiveness to cognitive remediation therapy in schizophreniaRafael Penadés, Nuria Pujol, Rosa Catalán, et al.
Schizophrenia Research|December 25, 2017
BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trialRafael Penadés, Irene López-Vílchez, Rosa Catalán, et al.
Revista De Psiquiatria Y Salud Mental|April 13, 2016
Validation of the Spanish version of the McLean Screening Instrument for Borderline Personality DisorderJoaquim Soler, Elisabet Domínguez-Clavé, Clemente García-Rizo, et al.
Pageof 6